SUDDEN CARDIAC-TAMPONADE AFTER CHEMOTHERAPY FOR MARROW TRANSPLANTATION IN THALASSEMIA

被引:37
作者
ANGELUCCI, E
MARIOTTI, E
LUCARELLI, G
BARONCIANI, D
CESARONI, P
DURAZZI, SMT
GALIMBERTI, M
GIARDINI, C
MURETTO, P
POLCHI, P
SGARBI, E
机构
[1] OSPED SAN SALVATORE PESARO,DIV CARDIOL,PESARO,ITALY
[2] OSPED SAN SALVATORE PESARO,SERV ANAT PATOL,PESARO,ITALY
[3] OSPED PESARO,CTR TRAPIANTI MIDOLLO OSSEO,I-61100 PESARO,ITALY
关键词
D O I
10.1016/0140-6736(92)91343-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Published work suggests that cardiac tamponade occurs only occasionally after bone-marrow transplantation (BMT) but the worrying number of cases encountered in the transplant programme in Pesaro, Italy, has led to an analysis of this complication. Cardiac tamponade occurred in 8 (2%) of 400 consecutive thalassaemic patients during conditioning for or within a month of BMT. 6 cases were fatal; these represented 9% of all causes of death and 29% of those occurring between start of conditioning regimen and 30 days post transplant. The syndrome was characterised by sudden onset of circulatory shock and cardiac arrest. The only effective treatment was immediate fluid removal. The absence of myocardial lesions and the complete resolution of the syndrome after pericardiocentesis suggest that the pericardial membranes played the main part in the pathogenesis of the syndrome. Since irradiation was not part of the conditioning regimen and since 3 of the affected patients had bacteraemia, the triggering factor for the syndrome could have been the drugs used for conditioning, acting alone or together with bacteraemia and trauma. The frequency with which we encountered the syndrome, and the similarity among our patients in clinical picture, and in characteristics of the effusion, indicate that cardiac tamponade occurring in thalassaemic patients after start of chemotherapy as conditioning for BMT is a specific syndrome requiring rapid treatment.
引用
收藏
页码:287 / 289
页数:3
相关论文
共 17 条
[1]  
APPELBAUM FR, 1976, LANCET, V1, P58
[2]  
BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P173
[3]  
BUJA LM, 1976, HUM PATHOL, V7, P15
[4]  
CAZIN B, 1986, CANCER, V57, P2061, DOI 10.1002/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO
[5]  
2-H
[6]   CARDIOTOXICITY ASSOCIATED WITH HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY [J].
GOTTDIENER, JS ;
APPELBAUM, FR ;
FERRANS, VJ ;
DEISSEROTH, A ;
ZIEGLER, J .
ARCHIVES OF INTERNAL MEDICINE, 1981, 141 (06) :758-763
[7]  
KUPARI M, 1990, BONE MARROW TRANSPL, V5, P91
[8]   BONE-MARROW TRANSPLANTATION IN THALASSEMIA [J].
LUCARELLI, G ;
GALIMBERTI, M ;
POLCHI, P ;
ANGELUCCI, E ;
BARONCIANI, D ;
DURAZZI, SMT ;
GIARDINI, C ;
NICOLINI, G ;
POLITI, P ;
ALBERTINI, F .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (03) :549-556
[9]   BONE-MARROW TRANSPLANTATION IN PATIENTS WITH THALASSEMIA [J].
LUCARELLI, G ;
GALIMBERTI, M ;
POLCHI, P ;
ANGELUCCI, E ;
BARONCIANI, D ;
GIARDINI, C ;
POLITI, P ;
DURAZZI, SMT ;
MURETTO, P ;
ALBERTINI, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (07) :417-421
[10]   MARROW TRANSPLANTATION IN PATIENTS WITH ADVANCED THALASSEMIA [J].
LUCARELLI, G ;
GALIMBERTI, M ;
POLCHI, P ;
GIARDINI, C ;
POLITI, P ;
BARONCIANI, D ;
ANGELUCCI, E ;
MANENTI, F ;
DELFINI, C ;
AURELI, G ;
MURETTO, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (17) :1050-1055